Clinical Trial

DRONE-WOUND Study: Severe Infection After Drone-Related Combat Trauma

Study acronym: DRONE-WOUND
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Drone-related combat injuries have become one of the most devastating mechanisms of injury in modern warfare. These injuries often cause extensive tissue devitalization, contamination, open fractures, vascular injuries, and complex soft tissue damage, which may substantially increase the risk of severe wound infection, multidrug-resistant bacterial infection, repeated surgical procedures, limb loss, and sepsis. However, the relationship between the extent of tissue devitalization and the development of severe infection has not been systematically investigated. The DRONE-WOUND Study is a prospective observational cohort study designed to evaluate the association between tissue devitalization and severe wound infection in patients with drone-related combat trauma. The study will collect detailed clinical, surgical, microbiological, and radiological data from injured patients treated at participating trauma centers. Measures of tissue injury, contamination, surgical management, microbiological findings, and infection outcomes will be analyzed to identify factors associated with severe infection and poor clinical outcomes. The findings of this study are expected to improve understanding of the mechanisms leading to infection after drone-related injuries, support early identification of high-risk patients, and inform future strategies for surgical management, antimicrobial therapy, and infection prevention in combat trauma. Ultimately, the study aims to improve limb salvage, reduce infectious complications, and enhance outcomes for patients with severe drone-related injuries.
Trial Details
NCT Number NCT07706608
Lead Sponsor Ukrainian Society of Regional Anesthesia and Pain Therapy
Conditions Combat Related Symptoms, Combat Trauma, Infection, Infection Complication, Wound - in Medical Care, Wound Infection Post-Traumatic, Surgical Site Infection (SSI)
Enrollment 500 participants
Start Date 2026-10-23
Primary Completion 2026-10-23 (estimated)
Study Completion 2026-10-23 (estimated)
Updated on ClinicalTrials.gov 2026-07-16